by Extivita | Mar 14, 2017 | Lymphoma
Abstract: Renal cell carcinoma (RCC) is well known that it cannot be treated with traditional chemotherapy or radiotherapy. 16-Hydroxycleroda-3,13-dien-15,16-olide (CD), isolated from Polyalthia longifolia Benth. & Hook. f. var. pendula had been reported to...
by Extivita | Jul 23, 2015 | Lymphoma
Abstract: We present the case of a 69 year-old gentleman with non-healing ulcers of the bilateral medial malleoli as a result of graft-versus-host disease (GvHD). The patient discussed was diagnosed with stage IV mantle cell lymphoma. Over the course of 4 years the...
by Extivita | Dec 10, 2014 | Lymphoma
Abstract: Hyperbaric oxygen (HBO) improves skin flap function and inhibits partial necrosis induced by ischemia-reperfusion (I/R) injury. Our study aimed to evaluate the mechanism underlying HBO regulation of the antiapoptosis factors associated with I/R injury of...
by Extivita | Nov 13, 2014 | Lymphoma
Abstract: To report 2 cases of central retinal artery occlusion (CRAO) that occurred within 24 hours of routine phacoemulsification cataract surgery using peribulbar anesthesia. Case 1: An otherwise well 76-year-old woman with right pseudoexfoliation syndrome and...
by Extivita | Jul 9, 2014 | Lymphoma
Abstract: Primary cutaneous γδ T-cell lymphoma and hemophagocytic syndrome (HPS) is a very rare disease process with only 41 cases of this type of lymphoma published to date. We report the case of a 56-year-old woman who developed high-grade fevers and multiple...
by Extivita | Dec 21, 2013 | Lymphoma
Abstract: The overexpression of B-cell activating factor (BAFF) in mucosa-associated lymphoid tissue (MALT) may decrease the efficacy of rituximab treatment in Sjögren’s syndrome (SS). Anti-CD20 therapy was effective on marginal zone B cells, in the murine model...
